Clincosm LogoSign in Get a demo

mantle cell lymphoma

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • TC-110 T Cells
  • +2 more
  • Denver, Colorado
  • +2 more
Jun 25, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

CD19 Positive, Mantle Cell Lymphoma, Recurrent DLBCL Trial in Houston (procedure, drug, biological)

Withdrawn
  • CD19 Positive
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2020

CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Houston (procedure, biological, drug)

Completed
  • CD20 Positive
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
May 30, 2019

Advanced Cancer, Colorectal Cancer, Mantle Cell Lymphoma Trial in France, United Kingdom, United States (Ramucirumab,

Completed
  • Advanced Cancer
  • +2 more
  • Birmingham, Alabama
  • +4 more
Mar 2, 2019

DLBCL, Transformed Follicular Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Alisertib (MLN8237), Rituximab, Vincristine)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Alisertib (MLN8237)
  • +2 more
  • Tucson, Arizona
  • +24 more
Feb 27, 2018

B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (SNS-032 Injection)

Completed
  • B-lymphoid Malignancies
  • +3 more
  • SNS-032 Injection
  • Duarte, California
  • +5 more
Apr 7, 2017

Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Completed
  • Mantle Cell Lymphoma
  • La Jolla, California
  • +56 more
May 27, 2016

Mantle Cell Lymphoma Trial in Worldwide (PCI-32765)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Stanford, California
  • +17 more
Aug 24, 2015

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Omaha, Nebraska
  • +4 more
Apr 19, 2012

Leukemia, Mantle Cell Lymphoma, Myelofibrosis Trial in Houston (RAD001)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    M.D. Anderson Cancer Center
Mar 20, 2012

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3

Terminated
Has Results
  • Hodgkin Disease
  • +3 more
  • Leuprolide acetate depot (LAD) 11.25 mg 3 Month
  • Matched placebo
  • Saint Louis, Missouri
  • +3 more
Apr 9, 2010

Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Mantle Cell Lymphoma
  • VELCADE TM (bortezomib) for Injection
  • Birmingham, Alabama
  • +34 more
Feb 7, 2008